Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates

Halozyme Therapeutics (HALO) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of$ 0.99 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 28.28%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 0.78 per share when it actually produced earnings of $0.91, delivering a surprise of 16.67%.Over the last fou ...